ArticleVaccines2020

Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis.

Charu Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.